|
Volumn 11, Issue 2, 2003, Pages 103-108
|
Chronic hepatitis B treated with domestic manufactured lamivudine in 2200 patients: a phase IV study
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
VIRUS DNA;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BLOOD;
CHILD;
CLINICAL TRIAL;
HEPATITIS B;
HUMAN;
LIVER;
MIDDLE AGED;
PATHOLOGY;
PHASE 4 CLINICAL TRIAL;
PSYCHOLOGICAL ASPECT;
QUALITY OF LIFE;
VIROLOGY;
ADOLESCENT;
ADULT;
AGED;
ANTIVIRAL AGENTS;
CHILD;
DNA, VIRAL;
HEPATITIS B E ANTIGENS;
HEPATITIS B, CHRONIC;
HUMANS;
LAMIVUDINE;
LIVER;
MIDDLE AGED;
QUALITY OF LIFE;
|
EID: 0142246171
PISSN: 10073418
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|